Prime Medical Donates Chlorine-Shielded Scrubs to the Tebow CURE Hospital in the Southern Philippines
LARGO, Fla., March 14, 2017 /PRNewswire/ -- Prime Medical, producer of SAF-T™ textiles for healthcare, has donated 117 sets of chlorine-shielded scrubs for the surgical team at Tebow CURE Hospital in Davao City, Philippines. The hospital specializes in pediatric orthopedic care and is part of the CURE International network of hospitals and specialty programs that operate around the world. In recognition of Tim Tebow's longstanding ties to the Philippines and his commitment to helping the less fortunate through his foundation, CURE has partnered with the Tim Tebow Foundation for this project.
"TEBOW CURE Hospital is proud to provide the highest quality care to children with serious but treatable conditions," said Leron Lehman, CURE Philippines Executive Director. "We are fortunate to have the support of Prime Medical to outfit our operating room staff in these specialized scrubs that provide an extra measure of protection against pathogens."
Prime Medical's SAF-T scrubs are made with a patented technology for textiles that binds chlorine to the surface of fabric. Utilizing this next-gen fabric technology is an important innovation to help protect patients and staff, as studies show that nearly 60% of clinician uniforms are regularly contaminated with harmful bacteria and viruses that can lead to healthcare acquired infections. When laundered per directions using EPA-registered bleach, the retained chlorine molecules can continuously kill bacteria and viruses on the fabric while the garments are in use, with no irritation or sensitivity to skin, and without fading the fabric.
As part of its Made to be More™ initiative, Prime Medical has donated more than 600 sets of bactericidal scrubs since 2014 to CURE International hospitals in Zambia and Zimbabwe. "We founded our business three years ago on the concept of 'Made to be More,' a philosophy that represents our products' intrinsic capabilities and our guiding principle that every individual has the ability to contribute to a better world," said Jim Sampey, CEO of Prime Medical. "By sharing our innovative medical apparel with organizations like CURE International, we proudly honor that commitment," said Sampey.
Utilizing textiles that can continuously kill germs is not only ground-breaking, but a much-needed method to fight infections in healthcare. Around the globe, the prevalence of multi-drug resistant organisms (MDROs) is on the rise. In February, the World Health Organization (WHO) released the first ever list of antibiotic-resistant "priority pathogens" that pose the greatest threat to human health. Along with the need to develop new antibiotics to combat superbugs, the WHO has called for better infection prevention methods. The WHO website states: "Without urgent action, we are headed for a post-antibiotic era, in which common infections and minor injuries can once again kill."
About Prime Medical
Prime Medical is the parent company and producer of SAF-T™ brand products including privacy curtains, bed linens, patient gowns, scrubs, lab coats and towels. Proudly made in the USA, Prime Medical products can contribute to a safer healthcare environment by harnessing the safe, trusted power of EPA-registered bleach. For more information, visit www.primemedical.com or www.saf-t-scrubs.com.
About CURE International
CURE International is a Christian health care network that operates charitable hospitals and programs in 30 countries worldwide where patients experience the life-changing message of God's love for them, receiving surgical treatment regardless of gender, religion, or ethnicity. Since 1998, CURE has had over 2.5 million patient visits, provided over 180,000 life-changing surgeries, and trained over 7,200 medical professionals.
Media Contacts:
Wendy Brady: (727) 999-2070
Marsha Strickhouser (727) 242-0770
[email protected]
SOURCE Prime Medical
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article